Literature DB >> 10544836

Causes of death in Korean patients with systemic lupus erythematosus: a single center retrospective study.

W U Kim1, J K Min, S H Lee, S H Park, C S Cho, H Y Kim.   

Abstract

OBJECTIVE: To determine the causes of death in Korean patients with systemic lupus erythematosus (SLE).
METHODS: We evaluated retrospectively Korean SLE patients who were monitored in the Center for Rheumatic Disease in Kang-Nam St. Mary's Hospital from 1993 to 1997 and who died.
RESULTS: Forty-three (7.9%) of 544 patients died. Comparison of demographics and disease activity indices between the deceased and the survivors showed that the age was older and C3 at presentation was lower in the deceased (n = 40) than the survivors (n = 453) (age: 33.8 +/- 13.6 versus 28.3 +/- 10.6 years, p = 0.02, C3: 36.8 +/- 21.4 versus 49.7 +/- 20.8 mg/dl, p = 0.03). Among 40 patients who died, the frequency and causes of death were as follows: 13 from infection (32.5%), 10 SLE-related factors (25.0%), 6 pulmonary hypertension (15.0%), 4 cerebrovascular accidents (10.0%), and 3 thrombotic thrombocytopenic purpura (7.5%). The majority of the SLE-related deaths were non-renal in origin, including 3 cerebral nervous system disease, 2 TTP, 2 acute pulmonary hemorrhage syndrome, 1 acute myocarditis, and 1 multi-system illness. SLE-related renal causes were responsible for only death. The major organisms of infection were gram negative bacilli (69.2%), primarily manifesting as sepsis or bacteremia (76.9%). The patients (n = 13) who died from infection had lower levels of complement and higher levels of anti-ds DNA antibody at presentation than those (n = 27) who died from the other causes (C3: 24.7 +/- 17.8 versus 41.7 +/- 21.5 mg/dl, p = 0.02, anti-dsDNA antibody: 68.0 +/- 73.5 versus 27.0 +/- 35.3 IU, p = 0.04). The mean steroid dose being administered one month before death was also higher in the patients who died of infection (30.5 +/- 15.2 versus 15.2 +/- 7.7 mg/day, p = 0.03). Patients who died of pulmonary hypertension, the third most common cause of mortality, showed extremely high pulmonary pressures at the initial diagnosis, with a short interval to death, and had less major organ involvement at death. There were no deaths due to coronary heart disease or neoplasm in this cohort.
CONCLUSION: The most common cause of death in 544 Korean lupus patients was infection, mainly manifesting as gram negative bacterial sepsis. SLE-related factors (mostly non-renal) were the next most frequent cause. Death from infection was associated with higher disease activity at presentation and a higher dose of steroid used previously. Death due to pulmonary hypertension was common, whereas death due to coronary heart disease was absent.

Entities:  

Mesh:

Year:  1999        PMID: 10544836

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  16 in total

1.  Fatal sepsis by Klebsiella pneumoniae in a patient with systemic lupus erythematosus: the importance of postmortem microbiological examination for the ex post diagnosis of infection.

Authors:  Cristian D'Ovidio; Arianna Pompilio; Valentina Crocetta; Giovanni Gherardi; Aldo Carnevale; Giovanni Di Bonaventura
Journal:  Int J Legal Med       Date:  2015-02-13       Impact factor: 2.686

2.  Changing trends in mortality in systemic lupus erythematosus? An analysis of SLE inpatient mortality at University Hospital Coventry and Warwickshire NHS Trust from 2007 to 2016.

Authors:  Himashi Anver; Shirish Dubey; James Fox
Journal:  Rheumatol Int       Date:  2019-09-30       Impact factor: 2.631

3.  Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus.

Authors:  K Manger; B Manger; R Repp; M Geisselbrecht; A Geiger; A Pfahlberg; T Harrer; J R Kalden
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

4.  Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome.

Authors:  Ayse Cefle; Murat Inanc; Mehmet Sayarlioglu; Sevil Kamali; Ahmet Gul; Lale Ocal; Orhan Aral; Meral Konice
Journal:  Rheumatol Int       Date:  2009-12-11       Impact factor: 2.631

5.  Fatal infection in children with lupus nephritis treated with intravenous cyclophosphamide.

Authors:  Kamolwish Laoprasopwattana; Pornsak Dissaneewate; Prayong Vachvanichsanong
Journal:  Pediatr Nephrol       Date:  2009-03-12       Impact factor: 3.714

6.  High mortality rate of (NZW x BXSB)F1 mice induced by administration of lipopolysaccharide attributes to high production of tumour necrosis factor-alpha by increased numbers of dendritic cells.

Authors:  N Koike-Kiriyama; Y Adachi; M Iwasaki; Y Amou; A Shigematsu; Y Koike; K Minamino; H Mukaide; M Shi; S Yanai; M Matsumura; S Ikehara
Journal:  Clin Exp Immunol       Date:  2008-09-08       Impact factor: 4.330

7.  Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension.

Authors:  Son-Mi Chung; Chang-Keun Lee; Eun Young Lee; Bin Yoo; Sang-Do Lee; Hee-Bom Moon
Journal:  Clin Rheumatol       Date:  2006-02-22       Impact factor: 2.980

8.  In-hospital mortality in patients with systemic lupus erythematosus: a study from Jordan 2002-2017.

Authors:  Marwan H Adwan; Ula Qasem; Khader N Mustafa
Journal:  Rheumatol Int       Date:  2020-03-07       Impact factor: 2.631

9.  Risk of infection in hospitalised children with systemic lupus erythematosus: a 10-year follow-up.

Authors:  Yu-Shu Chen; Yao-Hsu Yang; Yu-Tsai Lin; Bor-Luen Chiang
Journal:  Clin Rheumatol       Date:  2004-04-14       Impact factor: 2.980

Review 10.  Pulmonary hypertension in systemic lupus erythematosus: a systematic review and analysis of 642 cases in Chinese population.

Authors:  Y K Xia; S H Tu; Y H Hu; Y Wang; Z Chen; H T Day; K Ross
Journal:  Rheumatol Int       Date:  2012-09-16       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.